Report
Patrik Ling
EUR 95.03 For Business Accounts Only

Vimian (Buy, TP: SEK38.00) - Healthy underlying growth

We believe underlying market growth for the companion-animal space grew by c6% YOY in Q4, and for Vimian we expect organic growth of c10% YOY. We understand it plans to narrow the annual ordering programme (AOP) in Q1 to smooth the sales trend in the medical technology space. We expect no news on the litigation in the US with the sellers of VOI. We reiterate our BUY, but have cut our target price to SEK38 (40) on forecast changes.
Underlying
VIMIAN GROUP AB

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Patrik Ling

Other Reports on these Companies
Other Reports from DnB Markets

ResearchPool Subscriptions

Get the most out of your insights

Get in touch